bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 38 citations · 52 references
Life SciencesImmunologyInfectious DiseasesHost-pathogen InteractionsInnate ImmunityVirologyAntiviral ImmunityInnate Immune ResponseInterferon ResponsesViral InfectionsViral PathogenesisViral PathologyAntiviral Innate SignalingAntiviral Interferon ResponsesInterferon Response To Viral InfectionRna Virus BiologySars-cov-2 InfectionType Iii Interferon ResponseType Iii Interferon SignalingViral Rna Recognition
Abstract Lower respiratory tract infections are a leading cause of mortality driven by infectious agents. RNA viruses such as influenza virus, respiratory syncytial virus and the new pandemic coronavirus SARS-CoV-2 can be highly pathogenic. Clinical and experimental evidence indicate that most severe and lethal cases do not depend on the viral burden and are, instead, characterized by an aberrant immune response. In this work we assessed how the innate immune response contributes to the pathogenesis of RNA virus infections. We demonstrate that type III interferons produced by dendritic cells in the lung in response to viral recognition cause barrier damage and compromise the host tissue tolerance. In particular, type III interferons inhibit tissue repair and lung epithelial cell proliferation, causing susceptibility to lethal bacterial superinfections. Overall, our data give a strong mandate to rethink the pathophysiological roles of this group of interferons and their possible use in the clinical practice against endemic as well as emerging viral infections.
52
Virological assessment of hospitalized patients with COVID-2019
Roman Wölfel, Victor M. Corman, Wolfgang Guggemos et al. · Nature · 2020 · 7.2K citations · Full text
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen, Di Wu, Wei Guo et al. · Journal of Clinical Investigation · 2020 · 5.1K citations · Full text
Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola et al. · International Journal of Antimicrobial Agents · 2020 · 5K citations · Full text
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo, Benjamin E. Nilsson-Payant, Wen‐Chun Liu et al. · Cell · 2020 · 4.5K citations · Full text